Bimekizumab efficacy in high-impact areas: Pooled 2‑year analysis in scalp, nail, and palmoplantar psoriasis from phase 3/3b randomized controlled trials
posted on 2024-11-13, 12:52authored byAdis Journals on behalf of:, Joseph F Merola, Alice B Gottlieb, Andreas Pinter, Boni Elewski, Melinda Gooderham, Richard B Warren, Stefano Piaserico, Krista Wixted, Nancy Cross, Nicola Tilt, Susanne Wiegratz, Ulrich Mrowietz
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
The above video represents the opinions of the video. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).